Silihan lan utang jangka dawa perusahaan Apyx Medical (APYX)

Apyx Medical develops helium plasma-based lifting systems, leveraging exclusive patents and FDA clearances. Business growth is driven by the gradual upgrading of generators, as confirmed by the pricing chart on GURU.Markets, where long-term debt stands at 0.04. Scaling is achieved through educational courses for surgeons on the application of innovative devices in aesthetics.

Long-term debt records the total volume of financial obligations with a maturity of more than one year, serving as a measure of the issuer's leverage and long-term solvency. By analyzing the long-term borrowed capital chart, investors assess default risk or expansion potential, which for Apyx Medical (APYX) means financing the hiring of a commercial team while maintaining the protection of key R&D competencies.